Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy.

Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, Mao W, Chaudhary KR, Chaimowitz MG, Wong J, Selby M, Thudium KB, Korman AJ, Ulmert D, Thorek DL, DeWeese TL, Drake CG.

Clin Cancer Res. 2018 Jun 13. pii: clincanres.3427.2017. doi: 10.1158/1078-0432.CCR-17-3427. [Epub ahead of print]

PMID:
29898992
2.

Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy.

Peng LC, Narang AK, Gergis C, Radwan NA, Han P, Marciscano AE, Robertson SP, He P, Trieu J, Ram AN, McNutt TR, Griffith E, DeWeese TA, Honig S, Singh H, Greco SC, Tran PT, Deville C, DeWeese TL, Song DY.

Urol Oncol. 2018 Jun;36(6):309.e7-309.e14. doi: 10.1016/j.urolonc.2018.02.008. Epub 2018 Mar 16.

PMID:
29551548
3.

Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.

Marciscano AE, Madan RA.

Curr Treat Options Oncol. 2018 Mar 8;19(3):16. doi: 10.1007/s11864-018-0523-3. Review.

PMID:
29520448
4.

Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.

Chen L, Douglass J, Kleinberg L, Ye X, Marciscano AE, Forde PM, Brahmer J, Lipson E, Sharfman W, Hammers H, Naidoo J, Bettegowda C, Lim M, Redmond KJ.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):916-925. doi: 10.1016/j.ijrobp.2017.11.041. Epub 2017 Dec 5.

PMID:
29485071
5.

TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.

Francica BJ, Ghasemzadeh A, Desbien AL, Theodros D, Sivick KE, Reiner GL, Hix Glickman L, Marciscano AE, Sharabi AB, Leong ML, McWhirter SM, Dubensky TW Jr, Pardoll DM, Drake CG.

Cancer Immunol Res. 2018 Apr;6(4):422-433. doi: 10.1158/2326-6066.CIR-17-0263. Epub 2018 Feb 22.

PMID:
29472271
6.

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.

Marciscano AE, Walker JM, McGee HM, Kim MM, Kunos CA, Monjazeb AM, Shiao SL, Tran PT, Ahmed MM.

J Immunother Cancer. 2018 Jan 29;6(1):6. doi: 10.1186/s40425-018-0317-y.

7.

Avelumab demonstrates promise in advanced NSCLC.

Marciscano AE, Gulley JL.

Oncotarget. 2017 Nov 13;8(61):102767-102768. doi: 10.18632/oncotarget.22418. eCollection 2017 Nov 28. No abstract available.

8.

Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.

Muroyama Y, Nirschl TR, Kochel CM, Lopez-Bujanda Z, Theodros D, Mao W, Carrera-Haro MA, Ghasemzadeh A, Marciscano AE, Velarde E, Tam AJ, Thoburn CJ, Uddin M, Meeker AK, Anders RA, Pardoll DM, Drake CG.

Cancer Immunol Res. 2017 Nov;5(11):992-1004. doi: 10.1158/2326-6066.CIR-17-0040. Epub 2017 Oct 2.

9.

Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy.

Patel MA, Marciscano AE, Hu C, Jusué-Torres I, Garg R, Rashid A, Francis HW, Lim M, Redmond KJ, Rigamonti D, Kleinberg LR.

Front Oncol. 2017 Sep 4;7:200. doi: 10.3389/fonc.2017.00200. eCollection 2017.

10.

Evaluating Post-Radiotherapy Laryngeal Function with Laryngeal Videostroboscopy in Early Stage Glottic Cancer.

Marciscano AE, Charu V, Starmer HM, Best SR, Quon H, Hillel AT, Akst LM, Kiess AP.

Front Oncol. 2017 Jun 12;7:124. doi: 10.3389/fonc.2017.00124. eCollection 2017.

11.

LAG3 (CD223) as a cancer immunotherapy target.

Andrews LP, Marciscano AE, Drake CG, Vignali DA.

Immunol Rev. 2017 Mar;276(1):80-96. doi: 10.1111/imr.12519. Review.

12.

Long-term Outcomes With Planned Multistage Reduced Dose Repeat Stereotactic Radiosurgery for Treatment of Inoperable High-Grade Arteriovenous Malformations: An Observational Retrospective Cohort Study.

Marciscano AE, Huang J, Tamargo RJ, Hu C, Khattab MH, Aggarwal S, Lim M, Redmond KJ, Rigamonti D, Kleinberg LR.

Neurosurgery. 2017 Jul 1;81(1):136-146. doi: 10.1093/neuros/nyw041.

PMID:
28201783
13.

Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.

Hwang WL, Marciscano AE, Niemierko A, Kim DW, Stemmer-Rachamimov AO, Curry WT, Barker FG 2nd, Martuza RL, Loeffler JS, Oh KS, Shih HA, Larvie M.

Neuro Oncol. 2016 Jun;18(6):863-72. doi: 10.1093/neuonc/nov285. Epub 2015 Nov 22.

14.

Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.

Marciscano AE, Stemmer-Rachamimov AO, Niemierko A, Larvie M, Curry WT, Barker FG 2nd, Martuza RL, McGuone D, Oh KS, Loeffler JS, Shih HA.

J Neurosurg. 2016 Jan;124(1):106-14. doi: 10.3171/2015.1.JNS142228. Epub 2015 Aug 14.

PMID:
26274991
15.

Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature.

Khattab MH, Marciscano AE, Lo SS, Lim M, Laterra JJ, Kleinberg LR, Redmond KJ.

Case Rep Oncol Med. 2015;2015:431819. doi: 10.1155/2015/431819. Epub 2015 Jun 23.

16.

3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.

Schneider T, Chapiro J, Lin M, Geschwind JF, Kleinberg L, Rigamonti D, Jusué-Torres I, Marciscano AE, Yousem DM.

Eur Radiol. 2016 Mar;26(3):849-57. doi: 10.1007/s00330-015-3895-9. Epub 2015 Jul 3.

17.

Development of a novel multiplexed assay for quantification of transforming growth factor-β (TGF-β).

Pellicciotta I, Marciscano AE, Hardee ME, Francis D, Formenti S, Barcellos-Hoff MH.

Growth Factors. 2015 Apr;33(2):79-91. doi: 10.3109/08977194.2014.999367. Epub 2015 Jan 14.

PMID:
25586866
18.

Stereotactic body radiation therapy in pancreatic cancer: the new frontier.

Moningi S, Marciscano AE, Rosati LM, Ng SK, Teboh Forbang R, Jackson J, Chang DT, Koong AC, Herman JM.

Expert Rev Anticancer Ther. 2014 Dec;14(12):1461-75. doi: 10.1586/14737140.2014.952286. Epub 2014 Sep 3. Review.

PMID:
25183386
19.

Torus palatinus.

Vaduganathan M, Marciscano AE, Olson KR.

Proc (Bayl Univ Med Cent). 2014 Jul;27(3):259. No abstract available.

20.

Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.

Hardee ME, Marciscano AE, Medina-Ramirez CM, Zagzag D, Narayana A, Lonning SM, Barcellos-Hoff MH.

Cancer Res. 2012 Aug 15;72(16):4119-29. doi: 10.1158/0008-5472.CAN-12-0546. Epub 2012 Jun 12.

21.

Introduction to the medical professions through an innovative medical student-run pipeline program.

Nair N, Marciscano AE, Vivar KL, Schaeffer S, LaMont E, Francois F.

J Natl Med Assoc. 2011 Sep-Oct;103(9-10):832-8.

PMID:
22364050
22.

Management of high-risk localized prostate cancer.

Marciscano AE, Hardee ME, Sanfilippo N.

Adv Urol. 2012;2012:641689. doi: 10.1155/2012/641689. Epub 2011 Nov 1.

Supplemental Content

Loading ...
Support Center